Navigation Links
Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
Date:4/3/2008

hers, that future preclinical and clinical trials may not replicate results seen in previous clinical trials; that pre-clinical studies described in this press release may fail to indicate that the immunostimulant patch improves the immune response or reduces the necessary vaccine dosage by as much as anticipated; that the timing and effectiveness of the pre-clinical are dependent on sufficient coordination and cooperation with Merck and third parties; that potential collaborators, including Merck, may determine to wait for additional preclinical and/or clinical data prior to entering into a collaboration or may be unwilling to collaborate on terms Iomai deems acceptable; that Iomai may be unable to obtain the regulatory approvals necessary to conduct additional clinical trials or to market any product candidates using the Iomai's immunostimulant patch; that development costs may exceed expectations; that Iomai may fail to adequately protect its intellectual property or may be determined to infringe on the intellectual property of others; and the other risks identified under the heading "Risk Factors" in Iomai's annual report on Form 10-K for the year ended December 31, 2007 and filed with the Securities and Exchange Commission. Iomai cautions investors and others not to place undue reliance on the forward-looking statements contained in this press release. You are encouraged to read the Company's filings for a discussion of these and other risks and uncertainties which are filed with the Securities and Exchange Commission and available at http://www.sec.gov. All statements in this press release only speak as of its date, and Iomai undertakes no obligation to update or revise the statements.


'/>"/>
SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
2. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
3. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
4. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
5. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
9. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
10. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
11. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , 31 juli 2014 De Pfizer ... een rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor ... gevestigde PCRU is één van twee onderzoekseenheden ... als ideaal levens te verbeteren door de ontdekking en ... de PCRU op zoek naar mannen en vrouwen van ...
(Date:7/30/2014)... ARBOR, Mich. , July 30, 2014 Advanced ... first quarter (ending June 27, 2014) financial results on Monday, ... will be released after the close of the market and ... discuss the results at 4:30 p.m. EDT on the same ... Richard Kurtz (CEO and Director), Rob Risser ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... group purchasing contract with Premier will end on ... Premier GPO will be able to continue their ... Baycare, HPA, MedAssets, Novation, and ROi, in addition ... directly with Cepheid. "Cepheid has always ...
Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
... Aethlon Medical, Inc. (OTC Bulletin Board: ... filtration devices to address infectious disease and cancer, ... entitled: " A Platform to Address Bioterrorism." ... at: http://www.aethlonmedical.com/knowledge-center/special-reports/ ...
... 2010 Northwestern Memorial Hospital is one ... will test whether operable lung cancer patients and their ... by hardwiring data systems to reduce medical error and ... trial co-sponsored by the Commission on Cancer and the ...
Cached Medicine Technology:'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 2'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 3'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 4Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 2Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 3
(Date:7/31/2014)... 31, 2014 The average American drinks ... of $11.8 billion, and this is major cause of ... Institute in Woodland Hills and Oxnard, Calif. , That’s ... fluoride. , “Tap water is almost universally fluoridated,” said ... Institute. “Adding fluoride to municipal water supplies has drastically ...
(Date:7/31/2014)... Eden Lew has been awarded ... Crawford Technologies" Scholarship through EDSF (Electronic ... honor the contributions Chuck Forman made throughout his ... lost his battle with cancer on October 2, ... are thrilled to see her receive the second ...
(Date:7/31/2014)... Parsippany, NJ (PRWEB) July 31, 2014 A ... millions of people survive cancer and resume normal lives. This ... American Cancer Society, will affect one in seven American men ... are, has a five-year survival rate of nearly 100% and ... serious illness but most men diagnosed with the disease do ...
(Date:7/31/2014)... USHIO America’s Solid State Lighting ... lighting marketplaces, today announced the launch of its ... users to transform existing, inefficient lamp-based downlights to ... USHIO America’s Uphoria LED downlight retrofit kits fit ... the user to upgrade old incandescent recessed lighting ...
(Date:7/31/2014)... Upper Marlboro, MD (PRWEB) July 31, 2014 ... names in hair care, from Clairol to Shea Moisture. And ... roster: G’ Natural Herbal Products. Starting August 1, guests will ... , Founded in 1996 with $200 investment, CEO Roger Gore ... that his own hair was thinning and developing a receding ...
Breaking Medicine News(10 mins):Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 2Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 3Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 4Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 5Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 2Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 3Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 2Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 3Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 4Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2Health News:CVS Caremark Adds New, Natural Acclaimed Hair Care Line to its Beauty Roster 2
... International experts say there isn,t enough evidence to prove ... There,s not enough evidence to support a recent American ... for depression, according to international experts who contend the ... without any proof it would improve patient care. , ...
... counters editorial, , , TUESDAY, Nov. 11 (HealthDay News) -- ... strong, these vital nutrients don,t appear to help postmenopausal ... message is that there,s benefit from calcium and vitamin ... be doing much for breast cancer risk. You wouldn,t ...
... Urologychannel.com , a leader in patient education information and marketing services ... Center (OMC). The new Center offers free services to help urologists ... improve their practice website,s search engine presence. , ... ...
... a unique, customized gift,for the animal lover on your Christmas, ... (MAF) that benefits a favorite animal,-- dog, cat, horse or ... on your list. Many people who make a holiday gift ... holiday cards. A donation can be a,wonderful alternative to the ...
... carry cholesterol and triglycerides throughout the body , , TUESDAY, ... particles may increase the risk of high blood pressure ... That,s the conclusion of a new study by U.S. ... the Women,s Health Study. , Lipoprotein particles carry cholesterol ...
... 11 Ken Herron, Chief Marketing,Executive at Online ... that David S. Novak of the Centers for ... at Online Buddies, Inc. as the site,s first ... site for,gay men, with 2,000,000 members worldwide, is ...
Cached Medicine News:Health News:Study Questions Screening Heart Attack Patients for Depression 2Health News:Study Questions Screening Heart Attack Patients for Depression 3Health News:Calcium, Vitamin D Won't Prevent Breast Cancer 2Health News:Calcium, Vitamin D Won't Prevent Breast Cancer 3Health News:Innovative New Program Offers Free Online Services to Urologists 2Health News:Innovative New Program Offers Free Online Services to Urologists 3Health News:Unique Holiday Gift for Animal Lovers: A Donation to Fund Animal Health Research; Pick a Favorite Animal - Dog, Cat, Horse, All Species of Wildlife 2Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Stra...
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Straight shafts with 4 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches....
Medicine Products: